Ranitidine recall impacts Dr Reddy's P&L by Rs 40-crore
Dr Reddy's Laboratories which initiated a voluntary recall of its Ranitidine at the retail level for over-the-counter products and at the consumer level sold in the US due to confirmed contamination with N-Nitrosodimethylamine established by FDA following the ongoing investigation which reported carcinogenic impurity in the drug at low levels.
Share market update: Nifty Pharma index up; Dr. Reddy's Lab rises 1%
The Nifty Pharma index was trading 0.14 per cent up at 8118.65 around 10...
HSBC maintains hold on Dr Reddy's, revises target price to Rs 2,760
Hold Dr. Reddy's Laboratories Ltd. at a price target of Rs 2760.0 .
Share market update: 14 stocks hit 52-week highs on NSE
Overall, 43 shares were trading in green in Nifty50 index, while 6 were trading in the red.
Manmohan Singh hopes NCP-Shiv Sena-Congress to form govt in Maharashtra
On being asked if NCP-Shiv Sena-Congress will be able to form a government in Maharashtra, former prime minster Dr. Manmohan Singh said, “I ...
Jemima Khan seeks Dr D's help, says says she needs a way out of Pak media's madness
Pakistan media recently claimed that Wikipedia is Khan's cousin.
Why Dr D has no advice for the Thai King and his royal consort
In Thailand, it is illegal to defame, insult, or threaten the King, Queen, heir-apparent, or regent.
Dr Reddy's Q2 profit jumps twofold to Rs 1,093 crore on tax benefit
There was a tax benefit of Rs 330 crore due to recognition of deferred tax assets of Rs 520 crore.
Dr Reddy's gets 4 observations from USFDA for Srikakulam plant
"The audit of our API Srikakulam Plant (SEZ), Andhra Pradesh, by the USFDA, has been completed on October 25, 2019. We have been issued a Form 483 with four observations," said Dr Reddy's.
Dr Reddy’s recalled all batches of heartburn drug from US
Ranitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one of the largest suppliers of the drug. After FDA’s cautionary note, several Indian cos had to recall this product.
Dr Reddy's recalls all its ranitidine products in US
NDMA is classified as a probable human carcinogen based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
Buy Dr. Reddy's Laboratories, target Rs 2,850: CK Narayan
Buy Dr. Reddy's Laboratories Ltd. at a price target of Rs 2850.0 and a stoploss at Rs 2790 from entry point.
Share market update: Nifty Pharma index up; Glenmark Pharma rises 2%
The Nifty Pharma index was trading 1.03 per cent up at 7932.05 .
Share market update: 17 stocks hit 52-week highs on NSE
In the Nifty 50 index, Bharti Airtel, Bharti Infratel, Cipla and Tech Mahindra were among the top gainers.
Dr KN Modi University fetes entrepreneur Bina Modi for contribution to design, arts
The entrepreneur was lauded for building several successful brands that respond to the niche audience.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service